Evaluating the Efficacy of Current Treatments for Reducing Postoperative

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Post-operative Ileus

See also
Status	Clinical Trial	Phase
Terminated	`NCT00443040` - Asimadoline for the Treatment of Post-Operative Ileus	Phase 2
Recruiting	`NCT02673671` - G-Tech Feasibility Study for Early Detection of a Post-op Ileus
Terminated	`NCT01662115` - Nicotine Gum Recovery After Colorectal Surgery	Phase 4
Recruiting	`NCT04009954` - Post-operative Ileus and Gut Microbiota

See also

Status

Clinical Trial

Phase

Terminated

NCT00443040 - Asimadoline for the Treatment of Post-Operative Ileus

Phase 2

Recruiting

NCT02673671 - G-Tech Feasibility Study for Early Detection of a Post-op Ileus

Terminated

NCT01662115 - Nicotine Gum Recovery After Colorectal Surgery

Phase 4

Recruiting

NCT04009954 - Post-operative Ileus and Gut Microbiota

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01869231
Study type	Interventional
Source	Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Contact
Status	Completed
Phase	N/A
Start date	April 2010

Evaluating the Efficacy of Current Treatments for Reducing Postoperative Ileus

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms